We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Faes Farma SA (FAE) EUR0.1

Sell:€3.31 Buy:€3.34 Change: €0.045 (1.37%)
Market closed |  Prices as at close on 25 April 2024 | Switch to live prices |
Sell:€3.31
Buy:€3.34
Change: €0.045 (1.37%)
Market closed |  Prices as at close on 25 April 2024 | Switch to live prices |
Sell:€3.31
Buy:€3.34
Change: €0.045 (1.37%)
Market closed |  Prices as at close on 25 April 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Faes Farma SA is a Spain-based company engaged in the pharmaceutical industry. The Company specializes in the research, production, distribution and sale of prescription and generic drugs, over-the-counter (OTC) medicines, food supplements and personal care treatments, as well as raw materials for the pharmaceutical use. The Company’s research lines are mainly focused on the development of new drugs for the treatment of allergy, venous insufficiency and irritable bowel syndrome, among others. In addition, it provides animal nutrition products. The Company operates in Spain, Portugal, Chile and Mexico, among others. It controls a number of subsidiaries, such as Laboratorios Vitoria SA, Laboratorios Veris SA, Lazlo International SA, Ingaso Farm SLU, Esfion SA and Biotecnet I MAS D SA.

Contact details

Address:
Edificio 2, 2 Izquierda
MADRID
28033
Spain
Telephone:
+34 (914) 680800
Website:
https://faesfarma.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
FAE
ISIN:
ES0134950F36
Market cap:
€1.04 billion
Shares in issue:
311.25 million
Sector:
Pharmaceuticals
Exchange:
Madrid Stock Exchange
Country:
Unclassified
Currency:
Euro
Indices:
n/a

Key personnel

  • Mariano Ucar Angulo
    Executive Chairman of the Board
  • Valentin Ruiz Unamunzaga
    Deputy General Director, Corporate Chief Financial Officer
  • Gonzalo Lopez Casanueva
    General Director
  • Francisco Quintanilla Guerra
    General Director
  • Mariana Soroa Zubiria
    Deputy Director - Internal Audit and Compliance
  • Francisco Perez-Crespo Paya
    Non-Member Secretary of the Board

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.